Brief: Rovi Signs Agreement To Manufacture Pre-Filled Syringes For Global Pharmaceutical Company
25/04/2024 08:58
April 25 (Reuters) - Laboratorios Farmaceuticos ROVI SA
ROVI.MC :
* ANNOUNCES AGREEMENT TO MANUFACTURE PRE-FILLED SYRINGES
* AGREEMENT FOR GLOBAL PHARMACEUTICAL COMPANY
* AGREEMENT THROUGH ROVI PHARMA INDUSTRIAL SERVICES ('ROIS')
* PRODUCTION WILL TAKE PLACE ON ONE STATE-OF-THE-ART
HIGH-SPEED
FILLING LINE AT ROVI'S SUBSIDIARY'S (ROIS) FACILITY IN MADRID
* AGREEMENT WITH AN ESTIMATED ANNUAL CAPACITY OF 100 MILLION
UNITS
* AGREEMENT INCLUDES TECHNOLOGY TRANSFER FOR ASEPTIC FILLING
AND
HAS COMMERCIAL PRODUCTION TERM OF FIVE YEARS SUBJECT TO TERMS OF
AGREEMENT, BEGINNING ON DATE OF MANUFACTURE OF FIRST COMMERCIAL
LOT
* AFTER TECHNOLOGY TRANSFER AND REGULATORY APPROVAL,
COMMERCIAL
PRODUCTION IS EXPECTED TO COMMENCE IN 2026
* 2027 IS EXPECTED TO BE THE FIRST FULL RECURRENT
MANUFACTURING
YEAR
* ROVI'S GROUP CDMO DIVISION EXPECTS TO HAVE POSITIVE
REVENUES
INCREASE IMPACT RANGING BETWEEN 20% AND 45% OVER 2023 SALES
Source text for Workspace: ID:nCNM3kN03Q
Further company coverage: ROVI.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))